Literature DB >> 25276361

Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period.

Jiandong Mei1, Lunxu Liu1, Menglin Tang1, Ninghui Xu1, Qiang Pu1, Chengwu Liu1, Lin Ma1, Hui Shi1, Guowei Che1.   

Abstract

BACKGROUND: To observe the alterations in airway bacterial colonization during the perioperative period in patients with non-small cell lung cancer (NSCLC) and evaluate their clinical implications.
METHODS: Patients with resectable primary NSCLC were enrolled from October 2011 to April 2012. Airway secretions were harvested for microbiological study after admission, immediately after surgery, and before endotracheal extubation. Spontaneous sputum was collected when patients presented with signs of postoperative pneumonia (POP). Detailed data on the isolated pathogens were carefully recorded. Risk factors for airway colonization and POP were analyzed.
RESULTS: A total of 78 consecutive patients were enrolled. Fourteen patients (17.9%) had airway colonization at admission, including four cases of fungi and ten cases of Gram-negative bacilli (GNB). Five patients (6.4%) had colonized pathogens at the end of surgery, including three cases of GNB and two cases of Gram-positive cocci. Nine (11.5%) patients had positive culture of airway secretions collected before extubation, including seven cases of GNB and two cases of fungi. Eighteen patients (23.1%) had POP, of whom one suffered from bronchopleural fistula and one died of POP. Pathogens of POP were confirmed in 11 patients, including nine cases of GNB and two cases of fungi. Three patients had the same pathogens as preoperative colonization. The proportion of more antibiotic-resistant strains increased gradually. Advanced age [odds ratio (OR), 2.263; 95% confidence interval (95% CI), 1.030-4.970] and smoking (OR, 2.163; 95% CI, 1.059-4.429) were risk factors for airway colonization. Decreased diffusion capacity of the lung for carbon monoxide (OR, 5.838; 95% CI, 1.318-25.854), prolonged operation time (OR, 6.366; 95% CI, 1.349-30.033), and preoperative airway colonization (OR, 9.448; 95% CI, 2.206-40.465) were risk factors of POP.
CONCLUSIONS: Airway colonized pathogens altered and more antibiotic-resistant GNB emerged during the perioperative period. These pathogens played an important role in the presence of POP.

Entities:  

Keywords:  Airway bacterial colonization; non-small cell lung cancer (NSCLC); operation; pneumonia

Year:  2014        PMID: 25276361      PMCID: PMC4178084          DOI: 10.3978/j.issn.2072-1439.2014.07.07

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee.

Authors:  A J Mangram; T C Horan; M L Pearson; L C Silver; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1999-04       Impact factor: 3.254

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

3.  Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery.

Authors:  Jose Belda; Manuela Cavalcanti; Miquel Ferrer; Mireia Serra; Jorge Puig de la Bellacasa; Emilio Canalis; Antoni Torres
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

4.  Bronchial bacterial colonization in patients with resectable lung carcinoma.

Authors:  M Ioanas; J Angrill; X Baldo; F Arancibia; J Gonzalez; T Bauer; E Canalis; A Torres
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

5.  Airways colonizations in patients undergoing lung cancer surgery.

Authors:  Xavier Benoit D'Journo; Jean Marc Rolain; Christophe Doddoli; Didier Raoult; Pascal Alexandre Thomas
Journal:  Eur J Cardiothorac Surg       Date:  2011-01-08       Impact factor: 4.191

6.  [Bronchial bacterial colonization in patients with lung cancer].

Authors:  Maciej Dancewicz; Maria Szymankiewicz; Mariusz Bella; Joanna Swiniarska; Janusz Kowalewski
Journal:  Pneumonol Alergol Pol       Date:  2009

7.  Sources of pathogens causing pleuropulmonary infections after lung cancer resection.

Authors:  M Sok; A Z Dragas; J Erzen; J Jerman
Journal:  Eur J Cardiothorac Surg       Date:  2002-07       Impact factor: 4.191

8.  Bronchoalveolar lavage in the prediction of post-thoracotomy chest infection.

Authors:  M H Wansbrough-Jones; A Nelson; L New; A Wilson; N Wright; J R Pepper
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

9.  Postoperative pneumonia after major lung resection.

Authors:  Olivier Schussler; Marco Alifano; Herve Dermine; Salvatore Strano; Anne Casetta; Sergio Sepulveda; Aziz Chafik; Sophie Coignard; Antoine Rabbat; Jean-François Regnard
Journal:  Am J Respir Crit Care Med       Date:  2006-02-10       Impact factor: 21.405

10.  Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.

Authors:  D J Kearney; T H Lee; J J Reilly; M M DeCamp; D J Sugarbaker
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

View more
  10 in total

Review 1.  Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery.

Authors:  Shugeng Gao; Serena Barello; Liang Chen; Chun Chen; Guowei Che; Kaican Cai; Roberto Crisci; Antonio D'Andrilli; Andrea Droghetti; Xiangning Fu; Paolo Albino Ferrari; Hiran C Fernando; Di Ge; Guendalina Graffigna; Yunchao Huang; Jian Hu; Wenjie Jiao; Gening Jiang; Xiaofei Li; Hui Li; Shanqing Li; Lunxu Liu; Haitao Ma; Dongchun Ma; Guillermo Martinez; Giulio Maurizi; Kevin Phan; Kun Qiao; Majed Refai; Erino A Rendina; Guoguang Shao; Jianfei Shen; Hui Tian; Luca Voltolini; Jacopo Vannucci; Camilla Vanni; Qingchen Wu; Shidong Xu; Fenglei Yu; Song Zhao; Peng Zhang; Lanjun Zhang; Xiuyi Zhi; Chengchu Zhu; Calvin Ng; Alan D L Sihoe; Anthony M H Ho
Journal:  Transl Lung Cancer Res       Date:  2019-12

2.  Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patients.

Authors:  Maosong Ye; Xia Gu; Yang Han; Meiling Jin; Tao Ren
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

3.  Staged bilateral single-port thoracoscopic lung volume reduction surgery: A report of 11 cases.

Authors:  Miao Zhang; Heng Wang; Xue-Feng Pan; Wen-Bin Wu; Hui Zhang
Journal:  Exp Ther Med       Date:  2016-09-14       Impact factor: 2.447

4.  Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.

Authors:  Mengyao Sun; Yang Bai; Song Zhao; Xiyu Liu; Yongsheng Gao; Lei Wang; Bin Liu; Dashi Ma; Chunye Ma
Journal:  Oncotarget       Date:  2018-01-04

Review 5.  [Evidence and Practice of Enhanced Lung Recovery after Surgery 
in Patients Undergoing Lung Surgery].

Authors:  Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-06-20

6.  [Preoperatiove Airway Bacterial Colonization: the Missing Link between Non-small Cell Lung Cancer Following Lobectomy and Postoperative Pneumonia?]

Authors:  Ke Gao; Yutian Lai; Jian Huang; Yifan Wang; Xiaowei Wang; Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-04-20

Review 7.  [Enhanced Recovery after Surgery from Theory to Practice
What do We Need to Do?]

Authors:  Guowei Che; Lunxu Liu; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-04-20

Review 8.  [Status of perioperative airway management in patients with chronic obstructive pulmonary disease and lung cancer].

Authors:  Guowei Che; Xiuyi Zhi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-12

Review 9.  [Establishment and Optimization of Enhanced Recovery after Surgery System 
for Lung Cancer].

Authors:  Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-12-20

Review 10.  [Enhanced Lung Recovery after Surgery, Is It A Necessary for Precision Therapy?]

Authors:  Guowei Che; Lunxu Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.